The awful lesson of Thalidomide
The New York Times has taken a look at the awful history of Thalidomide, the drug which caused thousands of children around the world to be born with deformed and shortened limbs. It is deeply disturbing.
The New York Times has taken a look at the awful history of Thalidomide, the drug which caused thousands of children around the world to be born with deformed and shortened limbs. It is deeply disturbing. In the 1950s the German pharmaceutical company Chemie Grünenthal marketed it as a safe sleeping pill and as a remedy for morning sickness. Nowadays it is being used as to treat leprosy, especially in Brazil. Despite all the warnings, children are still being born there with severe defects. (Click here to see video.)
Michael Cook
Creative commons
clinical research
drug development
drug safety
Latest posts by Michael Cook (see all)
- Queensland legalises ‘assisted dying’ - September 19, 2021
- Is abortion a global public health emergency? - April 11, 2021
- Dutch doctors cleared to euthanise dementia patients who have advance directives - November 22, 2020
More Stories
A painful debate: shrinking the carbon footprint of anaesthetics
If there is any profession which seems remote from the Sturm und Drang of climate change, it must be anaesthetists....
Some patients recall death experiences after heart attacks
In an article in the journal Resuscitation, some survivors of cardiac arrest have described lucid death experiences that occurred while...
Queensland widower dies after taking assisted suicide drugs ordered by his wife
“Move along, please. Nothing to see here.” This was more or less the reaction of supporters of “voluntary assisted dying”...
Australian first: nurse donates organs after euthanasia
A Victorian woman has become the first Australian to combine death by euthanasia with organ donation. Ballarat nurse Marlene Bevern,...
Canadian study hints at crushing institutional conscience objections to ‘assisted dying’
Supporters of “voluntary assisted dying” fought hard to achieve legalisation in various jurisdictions around the world. After legalisation, however, battles...
Hope, hype and xenotransplantation
On January 7, 2022 David Bennett, a 57-year-old with terminal heart disease, made history as the first person to receive...